Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/1997
07/01/1997US5643578 Subunit vaccines
07/01/1997US5643577 Oral vaccine comprising antigen surface-associated with red blood cells
07/01/1997US5643576 Method of inducing an immune response with a live Venezuelan Equine Encephalitis virus expressing a heterologous immunogen
06/1997
06/26/1997WO1997022722A1 Genetic suppressor elements against human immunodeficiency virus
06/26/1997WO1997022701A1 Equine rhinovirus 1 proteins
06/26/1997WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies
06/26/1997WO1997022688A1 Heterophil-adapted poultry vaccine
06/26/1997WO1997022623A1 Osteo antiviral protein
06/26/1997WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/26/1997WO1997022613A1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
06/26/1997WO1997022368A2 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
06/26/1997WO1997022354A2 Use of a medicament and use of mixture of substances to produce a medicament
06/26/1997WO1997022346A2 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
06/26/1997WO1997022250A1 Therapeutic molecules generated by trans-splicing
06/26/1997WO1997022248A1 Composition for organ cryopreservation and treatment of viral and bacterial infections
06/26/1997WO1997013845A3 Phosphopantetheinyl transferases and uses thereof
06/26/1997DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector
06/26/1997DE19548624A1 Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New barbituric acid derivatives, processes for their preparation and medicaments containing these compounds
06/26/1997CA2241371A1 Genetic suppressor elements against human immunodeficiency virus
06/26/1997CA2240729A1 Use of a medicament and use of mixture of substances to produce a medicament
06/26/1997CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme
06/26/1997CA2240366A1 New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents
06/26/1997CA2240365A1 Covalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicaments
06/26/1997CA2240131A1 Composition for organ cryopreservation and treatment of viral and bacterial infections
06/25/1997EP0780393A1 Novel crystal of cephalosporin compound
06/25/1997EP0780390A1 Crystalline modification of CDCH, process for its preparation and pharmaceutical compositions containing it
06/25/1997EP0780122A1 Depressant of functions developed by molecule
06/25/1997EP0779923A2 Interleukin-1 type 3 receptors
06/25/1997EP0779893A2 Oligonucleotide prodrugs
06/25/1997EP0779885A1 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
06/25/1997EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases
06/25/1997EP0779817A1 Enteral vaccine for vaginal infections
06/25/1997EP0656886B1 N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors
06/25/1997EP0556248B1 Mycobacterium as adjuvant for antigens
06/25/1997EP0538486B1 Sewing machine needle and method of manufacturing same
06/25/1997CN1152940A Non-splicing variants of gp 350/220
06/25/1997CN1152935A Papillomavirus vaccines
06/25/1997CN1152916A Trifluoromethylquinoline carboxylic acid derivative
06/25/1997CN1152910A Difluorostatone antiviral agents
06/25/1997CN1152878A Improved modified live BRSV vaccine
06/25/1997CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor
06/25/1997CN1152866A Soap composition
06/25/1997CN1152575A New cephalosporing containing in position 7 substituted benzyloxyimino radical, their preparation process and intermediates, their use as medicaments
06/25/1997CN1152435A Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside
06/24/1997US5641889 Therapeutic nucleosides
06/24/1997US5641886 Process for preparation of N-tert.butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-phthalimidobutyl]-(4AS,8AS)-isoquinoline-3(S)-carboxamide
06/24/1997US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same
06/24/1997US5641874 DNA encoding bactericidal/permeability increasing proteins
06/24/1997US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same
06/24/1997US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis
06/24/1997US5641770 Thienamycins antibiotics
06/24/1997US5641763 N-phosphonylmethoxyalkyl derivatives of pyrimdine and purine bases and a therapeutical composition therefrom with antiviral activity
06/24/1997US5641761 Feeding crustacea food containing water-soluble schizophyllan and mycelia of schizophyllan-producing fungus
06/24/1997US5641760 Method of treating candida infection
06/24/1997US5641669 Platelet-activating factor acetylhydrolase
06/24/1997US5641662 Transfection of lung via aerosolized transgene delivery
06/24/1997US5641657 DNA encoding an interleukin-6 splice variant
06/24/1997US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia
06/24/1997US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage
06/24/1997US5641497 Gastrointestinal defensins, cDNA sequences and method for the production and use thereof
06/24/1997US5641492 Broad spectrum vaccine for immunizing animals against gramnegative bacteria comprising killed suspension of bacterial mutant, detoxified lipopolysaccharide immune modulator, protein and lipid binding carrier
06/24/1997US5641491 Escherichia coli strain 364 and use of said strain as a vaccine
06/24/1997US5641485 Caledothricins used in the treatment mycotic diseases
06/24/1997US5641475 Antiodor, antimicrobial and preservative compositions and methods of using same
06/19/1997WO1997021819A1 Novel nagpu
06/19/1997WO1997021815A2 Antifungal proteins
06/19/1997WO1997021814A1 Antifungal proteins
06/19/1997WO1997021727A1 Mycoplasma recombinant polypeptide vaccines
06/19/1997WO1997021712A1 Carbapenem-3-carboxylic acid ester derivatives
06/19/1997WO1997021708A1 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents
06/19/1997WO1997021685A1 Retroviral protease inhibiting compounds
06/19/1997WO1997021684A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
06/19/1997WO1997021683A1 Retroviral protease inhibiting compounds
06/19/1997WO1997021444A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
06/19/1997WO1997021431A1 Cobalt schiff base compounds
06/19/1997WO1997011666A3 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
06/19/1997DE19547160A1 Verwendung von Zuckerderivaten als antimikrobiell, antimykotisch und/oder antivirale Wirkstoffe Use of sugar derivatives as antimicrobial, antifungal and / or antiviral agents
06/19/1997DE19547022A1 Kovalente Lipid-Phosphonocarbonsäure-Konjugate, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel Covalent lipid phosphonocarboxylic acid conjugates, their preparation and their use as antiviral drugs
06/19/1997CA2509505A1 Retroviral protease inhibiting compounds
06/19/1997CA2273983A1 Process for the preparation of 9-deazaguanine derivatives
06/19/1997CA2240279A1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
06/19/1997CA2240183A1 Cobalt schiff base compounds
06/19/1997CA2239874A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
06/19/1997CA2239873A1 Antifungal proteins
06/19/1997CA2239731A1 Antifungal proteins
06/19/1997CA2238977A1 Retroviral protease inhibiting compounds
06/19/1997CA2211075A1 Carbapenem-3-carboxylic acid ester derivatives
06/18/1997EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses
06/18/1997EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas
06/18/1997EP0778894A1 Infectious peritonitis vaccine
06/18/1997EP0778847A1 Immunostimulatory agents
06/18/1997EP0778845A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids
06/18/1997EP0778843A1 Intermediates for dinucleotide and oligonucleotide analogues
06/18/1997EP0778780A1 Capsular polysaccharide immunomodulator
06/18/1997EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity
06/18/1997EP0778733A1 A basic protein composition for killing or inhibiting microbial cells
06/18/1997EP0778731A1 Ionene polymers containing biologically-active anions
06/18/1997EP0701562B1 Unsaturated phosphonates derivatives of purines and pyrimidines
06/18/1997EP0580635B1 Modified plant viruses as vectors